Anti-osteoporotic treatment does reduce the risk of fracture in real-life data
Randomized clinical trials suggest that anti-osteoporotic treatments increase bone mineral density (BMD) and hence reduce the risk of fractures. In this longitudinal cohort study, MD Giovanni Adami, presents the real-life effectiveness of anti-osteoporotic treatment in women at high risk of fracture.
Read more: Abstract: OP0239 Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study.
Get access to the article
If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.